Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
14,176,388
-
Share change
-
-883,230
-
Total reported value
-
$8,575,000
-
Put/Call ratio
-
14%
-
Price per share
-
$0.6050
-
Number of holders
-
46
-
Value change
-
-$682,762
-
Number of buys
-
21
-
Number of sells
-
15
Institutional Holders of ADAMIS PHARMACEUTICALS CORP - COM NEW (ADMP) as of Q4 2021
As of 31 Dec 2021 ADAMIS PHARMACEUTICALS CORP - COM NEW (ADMP) had 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 14,176,388 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, CITADEL ADVISORS LLC, STATE STREET CORP, NORTHERN TRUST CORP, Virtu Financial LLC, JPMORGAN CHASE & CO, and UBS Group AG.
This table shows 46 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.